Clinical research trials allow you, our patients, to work with us to help advance the field of sleep medicine. By working with us, you gain access to cutting edge treatments.
Phase 2 Randomized Double-Blind Placebo-Controlled 3-Period Single-Dose Crossover Study to Evaluate the Safety and Efficacy of Two Doses of AD-109 in Mild to Moderate Obstructive Sleep Apnea.
To this point, all of our treatments for sleep apnea have been mechanical or surgical. This study aims to assess whether an oral medicine improves mild to moderate obstructive sleep apnea.
A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants With Delayed Sleep-Wake Phase Disorder (DSWPD).
Multi-center, Double-blind, Parallel-group, Randomized, Placebo-controlled, Three Doses, 40-week Extension to Studies ID-078A301 and ID-078A302 to Assess the Long Term Safety and Tolerability of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder.
Please contact our clinical research coordinator, Liz Roben, for more information: